Lobe Sciences Ltd has announced the development of its initial Phase 1 study plan to demonstrate the safety and appropriate dosing range for its proprietary.
Lobe Sciences Ltd has announced the development of its initial Phase 1 study plan to demonstrate the safety and appropriate dosing range for its proprietary.
/PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of cannabis.
/PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of cannabis.
The Valens Company to Hold Conference Call to Discuss Financial Results for the Second Quarter of 2022 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.